Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report

BACKGROUND: The role of convalescent plasma therapy for patients with coronavirus disease 2019 (COVID‐19) is unclear. METHODS: We retrospectively compared outcomes in a cohort of critical COVID‐19 patients who received standard care (SC Group) and those who, in addition, received convalescent plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Omrani, Ali S., Zaqout, Ahmed, Baiou, Anas, Daghfal, Joanne, Elkum, Naser, Alattar, Rand A., Bakdach, Dana, Abusriwil, Hatem, Mostafa, Abdalrahman M., Alhariri, Bassem, Ambra, Naseem, Khatib, Mohamed, Eldeeb, Ali M., Merenkov, Zeyd, Fawzi, Zeinab, Hmissi, Saloua M., Hssain, Ali A., Coyle, Peter V., Alsoub, Hussam, Almaslamani, Muna A., Alkhal, Abdullatif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537323/
https://www.ncbi.nlm.nih.gov/pubmed/32965715
http://dx.doi.org/10.1002/jmv.26537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537323/
https://www.ncbi.nlm.nih.gov/pubmed/32965715
http://dx.doi.org/10.1002/jmv.26537

Ejemplares similares